Urgent

Acute hepatic porphyria / acute intermittent porphyria (AIP) attack

metabolic-genetic · Metabolic
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Inherited defect in haem synthesis (AIP most common) with attacks triggered by drugs (CYP inducers), fasting/low carbohydrate, alcohol, infection, hormonal changes. Classic triad: severe diffuse abdominal pain (no peritonism), neurovisceral features (autonomic instability, tachycardia, hypertension), and neuropsychiatric signs (confusion, seizures, peripheral/motor neuropathy). Hyponatraemia (SIADH) and dark/red urine on standing are clues. Attacks can be life-threatening (respiratory paralysis).

Red flags

  • Progressive motor weakness, bulbar or respiratory muscle involvement — risk of respiratory failure (ICU)
  • Severe hyponatraemia / seizures
  • Severe autonomic instability (labile BP, arrhythmia)
  • Use of an unsafe drug precipitating/prolonging the attack

Assessment

Differential diagnosis

  • Surgical acute abdomen (but porphyria has pain out of proportion, soft abdomen, no raised inflammatory markers typically)
  • Lead poisoning (also raises ALA, abdominal pain, neuropathy)
  • Guillain-Barré / other acute neuropathy
  • Hyponatraemia from other cause; thyroid storm; phaeochromocytoma (autonomic features)
  • Functional / somatic abdominal pain, drug withdrawal

Investigations

  • Spot urine porphobilinogen (PBG) and ALA (markedly raised during acute attack) — the key diagnostic test; protect sample from light
  • Urine may darken to port-wine colour on standing/light exposure
  • U&E (hyponatraemia/SIADH), magnesium, glucose, LFTs, CK
  • ECG + continuous monitoring (tachyarrhythmia, autonomic instability)
  • Review ALL medications against a porphyria-safe drug list
  • Later: enzyme/genetic confirmation and family screening (specialist / porphyria centre)

Management

  • Stop all potentially porphyrinogenic drugs; identify and treat triggers (infection, fasting, alcohol)
  • Give high carbohydrate: IV glucose 10% if unable to eat / mild attack; do not rely on glucose alone in severe attacks
  • Specific therapy: IV haem arginate (human hemin) early for moderate/severe attacks — shortens attack
  • Analgesia with SAFE drugs (opioids e.g. morphine) and antiemetics (ondansetron, prochlorperazine); use porphyria-safe list
  • Treat autonomic features: safe antihypertensive/rate control (beta-blocker e.g. propranolol, labetalol); safe seizure management
  • Manage hyponatraemia cautiously (often SIADH); careful fluid balance
  • Monitor for respiratory muscle weakness / bulbar involvement — escalate to ICU; contact specialist porphyria service
  • For recurrent attacks: prophylactic haem infusions or givosiran (specialist)

Drugs & doses

Glucose 10% IV infusion (high carbohydrate load) for mild attacks or when hemin unavailable
Haem arginate (human hemin / Normosang) 3 mg/kg IV once daily for 4 days (via large/central vein) — specialist, give early
Morphine or other safe opioid for analgesia; ondansetron / prochlorperazine for nausea (porphyria-safe)
Propranolol or labetalol for tachycardia/hypertension (safe); avoid unsafe antihypertensives [check porphyria drug database]
Seizures: treat correctable causes (hypoNa, hypoMg); use safer agents (levetiracetam, gabapentin) — avoid classic enzyme-inducing antiepileptics
Givosiran 2.5 mg/kg SC once monthly — for recurrent attacks, specialist (ENVISION trial) [verify local funding]

Disposition

Admit all acute attacks; HDU/ICU if neurological or respiratory involvement. Specialist porphyria service for hemin, confirmation and family screening. Provide safe-drug card.

Complications & pitfalls

  • Respiratory failure from neuropathy (may need ventilation)
  • Chronic/recurrent attacks, chronic pain, motor neuropathy
  • Hyponatraemia/SIADH, seizures
  • Long term (AIP): hypertension, CKD, hepatocellular carcinoma — surveillance

Exam pearls

  • Think porphyria when severe abdominal pain is OUT OF PROPORTION to a soft abdomen, with tachycardia, hyponatraemia and neuropsychiatric features and normal imaging/inflammatory markers.
  • Urine PBG/ALA during the attack is the diagnostic test — send it before giving glucose/hemin; protect from light.
  • IV hemin (haem arginate) is the specific treatment and should be given EARLY in moderate/severe attacks; glucose alone is for mild attacks only.
  • Always check every drug against a porphyria-safe list before prescribing; enzyme inducers precipitate attacks.
  • Givosiran (siRNA) once monthly reduces recurrent attacks (ENVISION) — refer recurrent cases to a porphyria centre.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.